Results: 4

1.
Fig. 2

Fig. 2. From: Management and outcome of stage 3 neuroblastoma.

Distribution of patients with stage 3 NB.

Shakeel Modak, et al. Eur J Cancer. ;45(1):90-98.
2.
Fig. 4

Fig. 4. From: Management and outcome of stage 3 neuroblastoma.

Kaplan–Meier analysis for event-free survival in patients with stage 3 NB.

Shakeel Modak, et al. Eur J Cancer. ;45(1):90-98.
3.
Fig. 1

Fig. 1. From: Management and outcome of stage 3 neuroblastoma.

Memorial Sloan-Kettering Cancer Centre (MSKCC) algorithm for management of patients with International Neuroblastoma (NB) Staging System (INSS) stage 3 NB.

Shakeel Modak, et al. Eur J Cancer. ;45(1):90-98.
4.
Fig. 3

Fig. 3. From: Management and outcome of stage 3 neuroblastoma.

Kaplan–Meier analysis for overall survival in patients with stage 3 NB: group A: patients with MYCN-non-amplified NB treated with surgical resection without chemotherapy; group B: MYCN-non-amplified NB patients treated with chemotherapy at non-MSKCC institutions prior to surgical resection and group C: patients with MYCN-amplified NB.

Shakeel Modak, et al. Eur J Cancer. ;45(1):90-98.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk